GUSTAVO REYES TERÁN MD CV Resume.
CV resume.

NAME: Gustavo Reyes-Terán
PLACE OF BIRTH: Mixtequilla, Oaxaca, MÉXICO
HOME ADDRESS: Cobreloa #47, C -101, Arboledas del Sur, México 14386, D.F. MÉXICO. Phone: (525) 5603-3158

WORK ADDRESS: Instituto Nacional de Enfermedades Respiratorias.
(National Institute of Respiratory Diseases)
Servicio de Infectología para Pacientes
Inmunocomprometidos (Unit of Infectious Diseases for
Immunocompromised Patients).
Calzada de Tlalpan # 4502,
Tlalpan 14080, México, D.F. MÉXICO.
Telephone: (525) 5666-4539, ext. 283
Fax: (525) 5666-7985
Beeper (Pager): 56299800, clave 990-1258
Cell- 044-55-3084-0106

DEGREES: M.D.
Universidad Nacional Autónoma de México (National University of Mexico). México City. 1984
MEDICAL LICENSE: 934559

Master in Public Health
Instituto Nacional de Salud Pública de México
(National Institute of Public Health). México City
1985

Master in Medical Sciences
National University of Mexico and Instituto Nacional de la Nutrición (National Institute of Nutrition). Mexico City.
1992-1995 (Pending Degree)

POSTGRADUATE TRAININGS: Residency in Internal Medicine
Hospital Central, PEMEX (. Mexico City.
1987-1990. With special mention

Residency in Infectious Diseases
Instituto Nacional de la Nutrición Salvador Zubirán.
(National Institute of Nutrition) México. 1990-1992.
POSTDOCTORAL STUDIES: Research Fellow in HIV
(Focus: pathogenesis of HIV disease)
Department of Medicine and Cancer Research Institute. University of California, San Francisco.
San Francisco, California, U.S.A. 1995-1996

PRESENT POSITION: Head, Unit of Infectious Diseases for Immunocompromised Patients. 1999 -
Researcher (Investigador titular). 1999-,
National Institute of Respiratory Diseases.

Sistema Nacional de Investigadores (Mexican System of Researchers): Member, Level-

AWARDS:

Scholarship from Consejo Nacional de Ciencia y Tecnología, CONACYT (National Council of
Science and Technology). National University of Mexico and National Institute of Nutrition, Mexico. 1992-1994.

Special mention for the Residency in Internal Medicine.

Gerhard Domack Prize. Award for the best clinical research in Infectious Diseases (Mexico, 1994). Mexican Society of Infectious Diseases 1994.

Invited speaker in the Tenth International Conference on AIDS. Yokohama, Japan, 7-12 August, 1994.

Research Fellow, Fogarty International Center (Fogarty International AIDS Training Program
(5 D43 TW00003-07) University of California, Berkeley, and University of California at San Francisco. 1995-1996

ARTICLES IN JOURNALS

Reyes-Teran G, Ramírez-Amador V, De la Rosa E, González-Guevara M, Ponce-de-León S. Major recurrent oral ulcers in AIDS: report of three cases. J Oral Pathol Med 1992;21(9)[September]:409-11

Reyes-Teran G, Llorente L. Sepsis y choque séptico: nuevas modalidades terapéuticas (Sepsis and septic shock: New therapeutic modalities. A review). Inflamacion 93 1992 (November-December);3:11-24 (Spain)

Reyes-Teran G, Ponce de León S. Las células T CD4+: consideraciones sobre su uso clínico en los pacientes con HIV/SIDA. (CD4+ T cells: CD4 T cells: considerations about their use in the care of HIV-1 infected patients. Rev Invest Clin 1993;45:363-70.

Reyes-Teran G, Alcocer-Varela J. Patogénesis de la infección por el virus de la inmunodeficiencia humana tipo 1 (Pathogenesis of HIV-1 infection: a review). Rev Invest Clin 1994 [November-December];46:113-147 (Mexico).

Camacho Mezquita FE, Reyes-Teran G. Chlamydia pneumoniae y aterogénesis. Enfermedades Infecciosas y Microbiología 1994;14:44-50

Reyes-Teran G, Ponce de León S. Los laberintos del SIDA. (The labyrinths of AIDS) Ciencias 1994 [January-March];(33):31-42.

Reyes-Teran G, Ponce de León S. Sobre el conteo de las células T CD4+. Rev Invest Clin 1994 (México);46:76 [Letter]

Reyes-Teran G, Ponce de León S. Sobre el conteo de las cT CD4+. Rev Invest Clin 1994 (México);46:165 [Letter].

Ramírez-Amador V, Reyes-Teran G, Ponce de León Se, Ponce de León Sa. Oral lesions of HIV-1 of HIV-1 infection in Mexico City. In: Oral manifestations of HIV infection. Eds. J.S. Greenspan and D Greenspan. 1995. Quintessence Publishing Co.,Inc.

Ponce de León S, Reyes-Teran G. La atención del paciente con SIDA (Medical Care of AIDS patients). Salud Pública Méx 1995;(Suppl 1] [In press].

Sifuentes-Osornio J, Porras-Cortés G, Bendall RP, Morales-Villarreal F, Reyes-Teran G, Ruiz-Palacios GM. Cyclospora cayetanensis infection in patients with and without AIDS. Biliary disease as another clinical manifestation. Clin Infect Dis 1995 (November);21(5) :1092-7.

Ramirez-Amador V, Sierra-Madero JG, Pedraza LE, de la Rosa Garcia E, Guevara MG, Reyes-Gutierrez E, Reyes-Teran G. Oral secondary syphilis in a patient with human immunodeficiency virus infection. Oral Surg, Oral Pathol, Oral Radiol and Endodontics 1996 (June) ;81(6):652-4.

Reyes-Teran G, Sierra-Madero JG, Martínez del Cerro V, Arroyo-Figueroa H, Pasquetti A, Calva JJ, Ruiz-Palacios GM. Effects of thalidomide on progressive weight loss in patients with advanced HIV disease. AIDS 1996 [November];10:1501-7.

Mackewicz CE, Barker E, Greco G, Reyes-Teran G, Levy JA. Do b-chemokines have clinical relevance in HIV infection? J Clin Invest 1997 (August 15) ;100 (4):921-30.

Locher C, Blackbourn DJ, Barnett SW, Murthy KK, Cobb EK, Rouse S, Greco G, Reyes-Teran G, Brasky KM, Carey KD, Levy JA. Superinfection with HIV-2 can reactivate virus production in baboons but is contained by a CD8+ T-cell antiviral response. J Infect Dis 1997;176 :941-7

Locher CP, Blackbourn DJ, Herndier BG, Reyes-Teran G, Barnett SW, Murthy KK, Levy JA. Transient Virus Infection and Pathogenesis of a New HIV Type 2 Isolate, UC12, in Baboons. AIDS Res Human Retrovirus 1998;14(1): 79-82

Locher C, Barnett SW, Herndier BG, Blackbourn DJ, Reyes-Teran G, Murthy KK, Brasky KM, Hubbard GB, Reinhart TA, Haase AT, Levy JA. Human Immunodeficiency Virus-2 Infection in Baboons is an Animal Model for Human Immunodeficiency Virus Pathogenesis in Humans. Arch Pathol Lab Med 1998;122(6):523-33.

Barker E, Mackewicz CE, Reyes-Teran G, Sato A, Stranford SA, Fujimura SH, Christopherson C, Chang S-Y, Levy JA. Virological and immunological features of long-term HIV infected individuals who have remained asymptomatic compared to those who have progressed to AIDS. Blood 1998;92:3105-3114.

Ramirez-Amador VA, Esquivel-Pedraza L, Ponce de Leon S, Reyes-Teran G, Sierra-Madero JG. Thalidomide as therapy for human immunodeficiency virus-related oral ulcers: a double-blind placebo-controlled clinical trial. Clin Infect Dis 1999;28:892-4.

Mourich DV, Lee S, Reyes-Terán G, Mackewicz CE and others. Lack differences in nef alleles among HIV-infected asymptomatic long-term survivors and those who progresser to disease. AIDS Res Human Retrovirus 1999 (Nov); 15(17):1573-1575.

Locher CP, Grant RM, Collison E, Reyes-Terán G, Elbeik T, Kahn J, and Levy JA. Antibody and cellular immune responses in breakthrough infection subjects after HIV type 1 glycoprotein 120 vaccination. AIDS Res Human Retrovirus 1999 (Dec); 15(18):1685-1689.

Zúñiga-Ramos J, Vargas-Alarcón G, Osnaya N, Flores C, Martínez-Tripp S, Granados J, Reyes-Terán G. Los factores genéticos determinantes de la resistencia a la infección por VIH y del control de la progresión al SIDA: Implicaciones sobre la patogénesis y las estrategias terapéuticas para la erradicación del VIH. Una revisión. Rev Invest Clin 2000;52(3):284-95.

Reyes-Terán G. SIDA en el INER. Revista del INER 2001.

Zúñiga J., Quiroz-Morales V., Barquera R., Osuna D., Flores E., Villarreal-Garza C., Vargas-Alarcón G., Granados J., Reyes-Terán G. Prevalence of polymorphysm in the ccr5 gene in Mexican Mestizo and Amerindian individuals and its biological relevance for HIV infection and transmission in Mexico. Submitted, AIDS 2002.

Zúñiga J., Quiroz-Morales V., Alvarado D., Granados J., Vargas-Alarcón G., Reyes-Terán G. HLA-B, HLA-DRB1, TNF-alpha and CCR5D32 allele and haplotype frequencies and susceptibility to HIV-1 infection in Mexicans. Submitted to AIDS, 2002.

Parra A, Reyes-Teran G, Ramirez-Peredo J, Jacquemin B, Quiroz V, Cárdenas M, , Veldhuis JD, Garcia-Sancho MC, Larrea F. Differential abnormalities in nocturnal rhythmic prolactin release in men with untreated and treated HIV-infection. Clin Endocrinol, 2002.

Torres KJ, Gutiérrez F, Reyes AS, Zúñiga J, Salgado G, Ridha S, Mayar ME, García-Sancho MC, Mackewicz CE, Reyes-Terán G. Effects of of highly active antiretroviral therapy (HAART) on the CD8+ T -cell noncytotoxic anti -HIV response in chronically HIV -infected individuals at intermediate and late stages of HIV disease. Manuscript in preparation. 2002.

Zúñiga-Roiz K., Hernández-Daly AC, Torres KJ, Zúñiga J, Mayar MA, García-Sancho MC, Reyes-Terán G. Highly active antiretroviral therapy based on protease inhibitor -sparing regimen reconstitutes muscle mass in HIV-infected individuals with wasting syndrome, but not in those with moderate or no weight loss. Manuscript in preparation. 2002. Manuscript in preparation. 2002.

BOOKS (as participant)

Reyes-Terán G. Diarrea (Diarrhea). In: Aguilar CA, Cortés J, Chevaille A, ed. Manual de Terapéutica Médica y Procedimientos de Urgencias (Manual of Medical Therapeutic and Urgency Procedures). 2th ed. México, D.F.: National Institute of Nutrition, MEXICO. 1993

Ramírez-Amador V, Reyes-Terán G, Ponce de león Se, Ponce de León Sa. Oral lesions of HIV-1 infection in Mexico City [Chapter 8]. In: Oral Manifestations of HIV Infection. J Greenspan, Editor. Ed. Quintaessence Publishing Co., Inc. Carol Stream, Illinois California. 1994. pp 53-59.

Ramírez-Amador V, Esquivel L, Reyes-Terán G. Neoplasia bucal y SIDA Oral tumors and AIDS). En: EDICIONES DE LA UNAM. Instituto Nacional de Cancerología. 1996. (Spanish)

Llorente L, Richaud-Patin Y, Reyes-Terán G. Red de citocinas. En: Las citocinas en las enfermedades reumáticas autoinmunes. Antonio Vidaller Palacín, Coordinador. Editorial IDEPSA (Internacional de ediciones y publicaciones, S.A.). Madrid, España (Spain). 1998. pp.15-29. ISBN: 84-7982-953-2

Ramírez-Amador V, Esquivel Pedraza L, de la Rosa E, Gonzalez M, Reyes-Terán G. Lesiones bucales asociadas con la infección por HIV (Oral lesions associated with HIV infection). Sa. Ponce de León y S. Rangel-Frausto Editores. Editorial Interamericana. México, D.F. 2000. pp

Reyes-Terán G. Patogénesis de la enfermedad por el virus de la inmunodeficiencia humana (HIV and the pathogenesis of AIDS). Sa. Ponce de León y S. Rangel-Frausto Editores. Editorial Interamericana. México, D.F. 2000. pp 39-114

ABSTRACTS PRESENTED IN CONGRESSES

Reyes-Terán G, Carrillo-Esper R, Ruíz-Macossay J. Polineuropatía del enfermo en estado crítico. Informe del primer caso en México. Rev Asoc Med Interna 1989;5:86 [Resumen 50]. MEXICO, 1989.
Reyes-Terán G, Rangel-Frausto S, Ponce de León S, Ruiz-Palacios GM. Tratamiento con ganciclovir de infecciones graves por citomegalovirus, en pacientes con SIDA y otras inmunodeficiencias. International Meeting of Infectious Diseases. Puerto Vallarta, Jal. MEXICO. November 14-17, 1990.
Reyes-Terán G, Ramírez V, Ponce de León S, Ruiz-Palacios G. Esteroides sistémicos como tratamiento de úlceras mayores recurrentes en pacientes con infección por VIH-1. Sociedad Mexicana de Infectología. VII Congreso Internacional de Infectología, Chihuahua, Chih. MEXICO, November 14-17, 1991.
Reyes-Terán G, Rangel-Frausto S, Ponce de León S, Ruiz-Palacios GM. Ganciclovir therapy of severe CMV infections. VIII International Conference on AIDS. Amsterdam, The Netherlands. July, 1992.
Ramírez-Amador V, Reyes E, Reyes-Terán, G, De-la-Rosa E, González M, Ponce-de-León S. HIV-1 oral ulcers with histopathological changes mimicking CMV infection. Second International Workshop on the Oral Manifestations, January 31-February 3, 1993, San Francisco, CA, USA.
Ramírez-Amador V, Reyes E, Reyes-Terán, G, De-la-Rosa E, González M, Ponce-de-León S. Ulceras bucales con cambios patológicos que semejan infección por CMV. Congreso anual de la Asociación Mexicana de Patología. Puebla, Puebla. 1993.
Reyes-Terán G, Arce-Salinas A, González-LaRiviere O, Larraza O, García-Cabrera L, Alcocer-Varela J. HIV-1 infection and systeì¥Á 5@ ð ¿ 6v
bjbjÏ2Ï2

4| ­X ­X E
ÿÿ ÿÿ ÿÿ ˆ ` ` ` ` ` ` ` t 8 8 8 8 p T Ä L t /o ð ? ? 2? 2? 2? 2? 2? 2? ¿e Áe Áe Áe / ðe < ,j < hn $ q R qs œ Œn ] ` "* 2? 2? "* "* Œn ` ` 2? 2? én ª< ª< ª< "* v ` 2? ` 2? ¿e ª< "* ¿e ª< Š ª< 4= f ¿` p ` ` ge 2? ?
@rÁÇ@-Â 8 ˜9 Ò /c D ‹e 4 ÿn 0 /o sc ô
t j; ?
t ˆ ge t t ` ` ` `
t ` ge $ 2? ° â! ¢ ª< "$ & ‚ 2? 2? 2? Œn Œn t t Ä 8 ˆ< " t t 8 G, Sierra-Madero JG, Martínez del Cerro V, Muñoz-Trejo T, Arroyo-Figueroa H, Pasquetti A, Calva JJ, Ruiz-Palacios GM. Effects of thalidomide on progressive weight loss in patients with late stage of HIV disease. Preliminary results of a clinical trial. Infectious Diseases Society of America. Orlando, Florida, USA. October 7-9, 1994.
Reyes-Terán G, Sierra-Madero JG, Martínez del Cerro V, Arroyo-Figueroa H, Pasquetti A, Calva JJ, Ruiz-Palacios GM. Efecto de talidomida (TAL) sobre el síndrome de desgaste (SD) asociado con la infección por el HIV-1. Resultados preliminares de un ensayo clínico con asignación aleatoria, doble ciego, comparado con placebo. Reunión de alumnos de Maestría y Doctorado. Universidad Nacional Autónoma de México (UNAM). Antigua Escuela de Medicina. México, D.F. México,1995.
Reyes-Terán G, Sierra-Madero JG, Martínez del Cerro V, Arroyo-Figueroa H, Pasquetti A, Calva JJ, Ruiz-Palacios GM. Efecto de talidomida (TAL) sobre el síndrome de desgaste (SD) asociado con la infección por el HIV-1. Resultados preliminares de un ensayo clínico con asignación aleatoria, doble ciego, comparado con placebo. Congreso anual del Consejo Nacional para la prevención y control del SIDA en México. México, D.F. México, 1995.
Ramírez-Amador V, Esquivel-Pedraza L, Ponce-de-León SE, Reyes-Terán G, De-La-Rosa-García E, González-Guevara M, Ponce-de-León SA, Sierra-Madero J. Tratamiento de las úlceras bucales recurrentes con talidomida en el paciente infectado con VIH. Ensayo clínico doble ciego controlado con placebo. XXII Congreso Anual de la Asociación Mexicana de Infectología y Microbiología Clínica. San Luis Potosí, SLP. Octubre 21-24, 1998.
Torres KJ, Gutiérrez F, Reyes AS, Zúñiga J, Salgado G, Ridha S, Mayar ME, Mackewicz CE, Reyes-Terán G. Effects of 6 months of highly active antiretroviral therapy (HAART) on the CD8+ T -cell noncytotoxic anti -HIV response (CNAR) in chronically HIV -infected individuals at intermediate and late stages of HIV disease. Abstract submitted. International Meeting on AIDS. Barcelona, Spain. July, 2002.

Zúñiga-Roiz K., Hernández-Daly AC, Torres KJ, Zúñiga J, Mayar MA, Reyes-Terán G. Highly active antiretroviral therapy based on protease inhibitor -sparing regimen reconstitutes muscle mass in HIV-infected individuals with wasting syndrome, but not in those with moderate or no weight loss. Abstract submitted. International Meeting on AIDS. Barcelona, Spain. July, 2002.

Zúñiga J., Quiroz-Morales V., Alvarado D., Granados J., Vargas-Alarcón G., Reyes-Terán G. HLA-B, HLA-DRB1, TNF-a and CCR5D32 allele and haplotype frequencies and susceptibility to HIV-1 infection in Mexicans. Abstract submitted. International Meeting on AIDS. Barcelona, Spain. July, 2002.

Clinical trials (Principal Investigator in Pharmaceutical Companies-sponsored Clinical Trials).

Reyes-Terán G. Glaxo Smithkline. Community-acquired pneumonia. 2000
Reyes-Terán G. Bristol Myers Squibb. Anti-HIV therapy. BMS Protocol 099, 2000
Reyes-Terán G. Bristol Myers Squibb. Anti-HIV therapy. BMS Protocol 110, 2001
Reyes-Terán G. Bristol Myers Squibb. Anti-HIV therapy. BMS Protocol 043, 2001
Reyes-Terán G. PPD Development. BMS. Anti-HIV therapy. Protocol 037, 2002
Reyes-Terán G. Bristol Myers Squibb. Anty-HIV therapy. Protocol 045, 2002
Reyes-Terán G. Triangle. Anti-HIV therapy. Protocol FTC (Emtricitabina), 2001

Back to home

Contact us.